Christopher Moxham
Vorstandsvorsitzender bei Rarebase, PBC
Aktive Positionen von Christopher Moxham
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Rarebase, PBC
 Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Vorstandsvorsitzender | 04.10.2023 | - |
| Präsident | 13.07.2023 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | - | 04.10.2023 |
Karriereverlauf von Christopher Moxham
Ehemalige bekannte Positionen von Christopher Moxham
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| FULCRUM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.02.2021 | - |
| Corporate Officer/Principal | 01.01.2019 | 05.02.2021 |
Ausbildung von Christopher Moxham
| Stony Brook University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Rarebase, PBC
Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Technology Services |
- Börse
- Insiders
- Christopher Moxham
- Erfahrung